Clinical Trial Update: Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether inhaled L-menthol reduces breathlessness in people with interstitial lung disease; enrollment is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Drugs mentioned

• L-menthol (L-menthol)

Snippet

Sponsor: Region Skane | Conditions: Interstitial Lung Disease (ILD) | Phase 2 | Status: RECRUITING